Pharmacological characterization of almotriptan: an indolic 5-HT receptor agonist for the treatment of migraine

By Bou J.   Domenech T.   Puig J.   Heredia A.   Gras J.   Fernandez-Forner D.   Beleta J.   Palacios J.M.  

European Journal of Pharmacology, Vol. 410, Iss. 1, 2000-12 ,pp. : 33-41

Elsevier

Access to resources Recommend Favorite

5HT1F- and 5HT7-Receptor Agonists for the Treatment of Migraines

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 4, 2007-08 ,pp. : 235-237

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Pharmacokinetics of Almotriptan, a Serotonin 5-HT 1B/1D Receptor Agonist for the Treatment of Migraine

By McEnroe Janet D.   Fleishaker Joseph C.  

Clinical Pharmacokinetics, Vol. 44, Iss. 3, 2005-01 ,pp. : 237-246

Adis International

Access to resources Recommend Favorite

Rizatriptan: a new 5-HT_1B/1D receptor agonist for the treatment of migraine

By Dahlof C.   Lines C.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 5, 1999-05 ,pp. : 671-685

Informa Healthcare

Access to resources Recommend Favorite

Targeting to 5-HT1F Receptor Subtype for Migraine Treatment: Lessons from the Past, Implications for the Future

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 12, Iss. 4, 2012-12 ,pp. : 241-249

Bentham Science Publishers

Access to resources Recommend Favorite